Lactate induces synapse-specific potentiation on CA3 pyramidal cells of rat hippocampus.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 09 07 2020
accepted: 31 10 2020
entrez: 12 11 2020
pubmed: 13 11 2020
medline: 2 1 2021
Statut: epublish

Résumé

Neuronal activity within the physiologic range stimulates lactate production that, via metabolic pathways or operating through an array of G-protein-coupled receptors, regulates intrinsic excitability and synaptic transmission. The recent discovery that lactate exerts a tight control of ion channels, neurotransmitter release, and synaptic plasticity-related intracellular signaling cascades opens up the possibility that lactate regulates synaptic potentiation at central synapses. Here, we demonstrate that extracellular lactate (1-2 mM) induces glutamatergic potentiation on the recurrent collateral synapses of hippocampal CA3 pyramidal cells. This potentiation is independent of lactate transport and further metabolism, but requires activation of NMDA receptors, postsynaptic calcium accumulation, and activation of a G-protein-coupled receptor sensitive to cholera toxin. Furthermore, perfusion of 3,5- dihydroxybenzoic acid, a lactate receptor agonist, mimics this form of synaptic potentiation. The transduction mechanism underlying this novel form of synaptic plasticity requires G-protein βγ subunits, inositol-1,4,5-trisphosphate 3-kinase, PKC, and CaMKII. Activation of these signaling cascades is compartmentalized in a synapse-specific manner since lactate does not induce potentiation at the mossy fiber synapses of CA3 pyramidal cells. Consistent with this synapse-specific potentiation, lactate increases the output discharge of CA3 neurons when recurrent collaterals are repeatedly activated during lactate perfusion. This study provides new insights into the cellular mechanisms by which lactate, acting via a membrane receptor, contributes to the memory formation process.

Identifiants

pubmed: 33180836
doi: 10.1371/journal.pone.0242309
pii: PONE-D-20-21322
pmc: PMC7660554
doi:

Substances chimiques

Receptors, N-Methyl-D-Aspartate 0
Lactic Acid 33X04XA5AT
Cholera Toxin 9012-63-9
Protein Kinase C EC 2.7.11.13
Calcium-Calmodulin-Dependent Protein Kinase Type 2 EC 2.7.11.17
Oxamic Acid QU60N5OPLG
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0242309

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Biochim Biophys Acta. 2007 Apr;1768(4):941-51
pubmed: 17261268
J Neurosci. 2008 May 7;28(19):4888-96
pubmed: 18463242
J Biol Chem. 2009 Jan 30;284(5):2811-22
pubmed: 19047060
Neuroscience. 2020 Jan 7;:
pubmed: 31917351
J Neurosci. 2019 Jun 5;39(23):4422-4433
pubmed: 30926749
Brain Res Rev. 2010 May;63(1-2):149-59
pubmed: 19879896
Science. 2007 Feb 16;315(5814):961-6
pubmed: 17303747
J Neurosci. 1997 Dec 15;17(24):9448-57
pubmed: 9391000
Hippocampus. 1994 Jun;4(3):374-91
pubmed: 7842058
Anesthesiology. 1992 Oct;77(4):728-34
pubmed: 1416170
Hippocampus. 2018 Aug;28(8):557-567
pubmed: 29704292
PLoS One. 2013 Aug 12;8(8):e71721
pubmed: 23951229
Front Neurosci. 2014 Dec 05;8:398
pubmed: 25538552
J Cereb Blood Flow Metab. 2002 Mar;22(3):271-9
pubmed: 11891432
J Biol Chem. 1997 Sep 26;272(39):24252-6
pubmed: 9305878
J Comp Neurol. 1990 May 22;295(4):580-623
pubmed: 2358523
Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13304-9
pubmed: 8917586
Nature. 1995 Jul 20;376(6537):256-9
pubmed: 7617037
Glia. 2012 Apr;60(4):674-80
pubmed: 22290492
J Neurochem. 1997 Oct;69(4):1484-90
pubmed: 9326277
Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):4264-9
pubmed: 16537519
Front Integr Neurosci. 2016 Mar 03;10:10
pubmed: 26973477
J Pharmacol Exp Ther. 2012 Jun;341(3):794-801
pubmed: 22434674
PLoS One. 2014 Mar 26;9(3):e93041
pubmed: 24671202
Cereb Cortex. 2014 Oct;24(10):2784-95
pubmed: 23696276
Mol Psychiatry. 2018 Feb;23(2):392-399
pubmed: 27752076
Cell Mol Neurobiol. 2005 Jun;25(3-4):649-61
pubmed: 16075383
Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5829-31
pubmed: 2062861
Trends Pharmacol Sci. 2009 Nov;30(11):557-62
pubmed: 19837462
Magn Reson Med. 1992 May;25(1):187-94
pubmed: 1593951
Cell. 2011 Mar 4;144(5):810-23
pubmed: 21376239
Science. 2002 Jul 12;297(5579):211-8
pubmed: 12040087
Horm Metab Res. 1993 Nov;25(11):560-3
pubmed: 8288157
J Physiol. 1999 Jul 15;518 ( Pt 2):497-506
pubmed: 10381595
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14397-402
pubmed: 14608033
Neuron. 2008 Jan 10;57(1):108-20
pubmed: 18184568
Exp Neurol. 1988 Dec;102(3):314-7
pubmed: 2848709
Front Neuroenergetics. 2012 Mar 19;4:5
pubmed: 22457647
Mol Psychiatry. 2009 May;14(5):537-45
pubmed: 18180759
Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10625-9
pubmed: 7938003
Trends Neurosci. 2013 Jul;36(7):396-404
pubmed: 23639382
Science. 1988 Jun 3;240(4857):1326-8
pubmed: 3375817
Nat Commun. 2014;5:3284
pubmed: 24518663
Neurosci Lett. 1997 Aug 22;232(1):17-20
pubmed: 9292881
Nat Rev Neurosci. 2012 Feb 15;13(3):169-82
pubmed: 22334212
J Physiol. 1998 Feb 15;507 ( Pt 1):237-47
pubmed: 9490845
J Neurochem. 2012 Mar;120(6):1014-25
pubmed: 22299833
Pflugers Arch. 2018 Sep;470(9):1377-1389
pubmed: 29808353
J Physiol. 2013 Nov 15;591(22):5525-40
pubmed: 23981714
J Biol Chem. 1995 Jun 2;270(22):12984-9
pubmed: 7768889
Learn Mem. 2009 May 23;16(6):387-94
pubmed: 19470655
Science. 1994 Sep 23;265(5180):1878-82
pubmed: 7916482
Brain Res. 2006 Oct 30;1117(1):213-23
pubmed: 16996036
Neuroscience. 2001;104(2):371-8
pubmed: 11377841
J Cereb Blood Flow Metab. 2015 Oct;35(10):1561-9
pubmed: 26036941
Neurosci Lett. 1996 Mar 22;207(1):70-2
pubmed: 8710213
Epilepsia. 2019 Dec;60(12):2370-2385
pubmed: 31755997
Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12228-33
pubmed: 25071212
PLoS One. 2011;6(12):e28427
pubmed: 22180782

Auteurs

Gabriel Herrera-López (G)

Departamento de Farmacobiología, Cinvestav Sede Sur, México City, México.

Ernesto Griego (E)

Departamento de Farmacobiología, Cinvestav Sede Sur, México City, México.

Emilio J Galván (EJ)

Departamento de Farmacobiología, Cinvestav Sede Sur, México City, México.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH